Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
1999 1
2000 1
2002 6
2003 7
2004 9
2005 14
2006 2
2007 14
2008 11
2009 6
2010 8
2011 6
2012 6
2013 11
2014 11
2015 4
2016 7
2017 9
2018 6
2019 13
2020 11
2021 12
2022 22
2023 9
2024 15
2025 16

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

217 results

Results by year

Filters applied: . Clear all
Page 1
Kidney Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.
Motzer RJ, Jonasch E, Agarwal N, Alva A, Baine M, Beckermann K, Carlo MI, Choueiri TK, Costello BA, Derweesh IH, Desai A, Ged Y, George S, Gore JL, Haas N, Hancock SL, Kapur P, Kyriakopoulos C, Lam ET, Lara PN, Lau C, Lewis B, Madoff DC, Manley B, Michaelson MD, Mortazavi A, Nandagopal L, Plimack ER, Ponsky L, Ramalingam S, Shuch B, Smith ZL, Sosman J, Dwyer MA, Gurski LA, Motter A. Motzer RJ, et al. Among authors: madoff dc. J Natl Compr Canc Netw. 2022 Jan;20(1):71-90. doi: 10.6004/jnccn.2022.0001. J Natl Compr Canc Netw. 2022. PMID: 34991070 Free PMC article.
NCCN Guidelines® Insights: Kidney Cancer, Version 2.2024.
Motzer RJ, Jonasch E, Agarwal N, Alva A, Bagshaw H, Baine M, Beckermann K, Carlo MI, Choueiri TK, Costello BA, Derweesh IH, Desai A, Ged Y, George S, Gore JL, Gunn A, Haas N, Johnson M, Kapur P, King J, Kyriakopoulos C, Lam ET, Lara PN, Lau C, Lewis B, Madoff DC, Manley B, Michaelson MD, Mortazavi A, Ponsky L, Ramalingam S, Shuch B, Smith ZL, Sosman J, Sweis R, Zibelman M, Schonfeld R, Stein M, Gurski LA. Motzer RJ, et al. Among authors: madoff dc. J Natl Compr Canc Netw. 2024 Feb;22(1):4-16. doi: 10.6004/jnccn.2024.0008. J Natl Compr Canc Netw. 2024. PMID: 38394781
Reply.
Charalel RA, Mushlin AI, Mao J, Fortune B, Madoff DC, Johnson MS, Sedrakyan A. Charalel RA, et al. Among authors: madoff dc. J Am Coll Radiol. 2024 Sep;21(9):1331-1332. doi: 10.1016/j.jacr.2024.04.010. Epub 2024 May 7. J Am Coll Radiol. 2024. PMID: 38719105 No abstract available.
Transarterial chemoembolisation combined with lenvatinib plus pembrolizumab versus dual placebo for unresectable, non-metastatic hepatocellular carcinoma (LEAP-012): a multicentre, randomised, double-blind, phase 3 study.
Kudo M, Ren Z, Guo Y, Han G, Lin H, Zheng J, Ogasawara S, Kim JH, Zhao H, Li C, Madoff DC, Ghobrial RM, Kawaoka T, Gerolami R, Ikeda M, Kumada H, El-Khoueiry AB, Vogel A, Peng X, Mody K, Dutcus C, Dubrovsky L, Siegel AB, Finn RS, Llovet JM; LEAP-012 investigators. Kudo M, et al. Among authors: madoff dc. Lancet. 2025 Jan 18;405(10474):203-215. doi: 10.1016/S0140-6736(24)02575-3. Epub 2025 Jan 8. Lancet. 2025. PMID: 39798578 Clinical Trial.
Randomized Phase 3 LEAP-012 Study: Transarterial Chemoembolization With or Without Lenvatinib Plus Pembrolizumab for Intermediate-Stage Hepatocellular Carcinoma Not Amenable to Curative Treatment.
Llovet JM, Vogel A, Madoff DC, Finn RS, Ogasawara S, Ren Z, Mody K, Li JJ, Siegel AB, Dubrovsky L, Kudo M. Llovet JM, et al. Among authors: madoff dc. Cardiovasc Intervent Radiol. 2022 Apr;45(4):405-412. doi: 10.1007/s00270-021-03031-9. Epub 2022 Feb 4. Cardiovasc Intervent Radiol. 2022. PMID: 35119481 Free PMC article. Clinical Trial.
Oncopharmacology in Interventional Radiology.
Raja J, Madoff DC. Raja J, et al. Among authors: madoff dc. Semin Intervent Radiol. 2022 Nov 17;39(4):411-415. doi: 10.1055/s-0042-1758076. eCollection 2022 Aug. Semin Intervent Radiol. 2022. PMID: 36406031 Free PMC article. Review.
Noninvasive Tumor Profiling: Quantitative Contrast-Enhanced MRI Markers Predict PD-L1 and CTNNB1 Status in Hepatocellular Carcinoma.
Matuschewski NJ, Sobirey R, Revzin M, Zeevi T, Gross M, Kasolowsky V, Shewarega A, Meister E, Kao T, Tefera J, Bousabarah K, Batra R, Strazzabosco M, Lin M, Gebauer B, Savic LJ, Duncan J, Madoff DC, Zhang X, Chapiro J. Matuschewski NJ, et al. Among authors: madoff dc. Radiology. 2025 Aug;316(2):e242750. doi: 10.1148/radiol.242750. Radiology. 2025. PMID: 40762840
Combined portal and hepatic vein embolisation in perihilar cholangiocarcinoma.
Smits J, Chau S, James S, Korenblik R, Tschögl M, Arntz P, Bednarsch J, Abreu de Carvalho L, Detry O, Erdmann J, Gruenberger T, Hermie L, Neumann U, Sandström P, Sutcliffe R, Denys A, Melloul E, Dewulf M, van der Leij C, van Dam RM; EuroLVD and DRAGON Trials Collaborative. Smits J, et al. HPB (Oxford). 2024 Dec;26(12):1458-1466. doi: 10.1016/j.hpb.2024.07.407. Epub 2024 Jul 16. HPB (Oxford). 2024. PMID: 39277435 Free article.
Proceedings from an international consensus meeting on ablation in urogenital diseases.
Iezzi R, Contegiacomo A, De Filippis A, Gunn AJ, Atwell T, Mcclure T, Jing Z, Posa A, Scrofani AR, Maresca A, Madoff DC, Goldberg SN, Kelekis A, Filippiadis D, Sala E, Ahmed M. Iezzi R, et al. Among authors: madoff dc. Insights Imaging. 2024 Nov 8;15(1):267. doi: 10.1186/s13244-024-01841-2. Insights Imaging. 2024. PMID: 39514046 Free PMC article.
Controversies of preoperative portal vein embolization.
May BJ, Madoff DC. May BJ, et al. Among authors: madoff dc. Hepat Oncol. 2016 Apr;3(2):155-166. doi: 10.2217/hep-2015-0004. Epub 2016 Mar 29. Hepat Oncol. 2016. PMID: 30191035 Free PMC article. Review.
217 results